Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 1201 - 1225 of 1335 in total

(2S)-2-({4-[(2S)-1-(2-Amino-4-oxo-1,4-dihydro-6-quinazolinyl)-3-{[2-({(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]tetrahydro-2-furanyl}amino)-2-oxoethyl]amino}-2-hydroxy-2-propanyl]benzoyl}ami no)pentanedioic acid

Experimental

(S)-Hmg-Coa

Experimental

N-Pyridoxyl-7-Keto-8-Aminopelargonic Acid-5'-Monophosphate

Experimental

N-Pyridoxyl-Threonine-5-Monophosphate

Experimental

PD-98059

PD-98059 is an inhibitor of MAP-kinase kinase activation.
Investigational
Matched Categories: … Calcium-Calmodulin-Dependent Protein Kinases, antagonists & inhibitors …

Lpc-Ether

Experimental

2',3'-dideoxy-3'-fluoro-urididine-5'-diphosphate

Experimental

3'-deoxy-3'-aminothymidine monophosphate

Experimental

4-AMINO-2-TRIFLUOROMETHYL-5-HYDROXYMETHYLPYRIMIDINE PYROPHOSPHATE

Experimental

Vitamin B6 Complexed with 2-Amino-Hexanoic Acid

Experimental

Nicotinamide-adenine-dinucleotide-5-hydroxy-4-oxonorvaline

Experimental

PF-07304814

PF-07304814 is a small molecule prodrug that targets the 3CLpro protease (Mpro), which is used by viruses like SARS-CoV-2 to assemble and multiply . Once administered through intravenous infusion, the compound is cleaved into PF-00835231 to exert its anti-viral effects . PF-07304814, developed by Pfizer, was first identified during the...
Investigational

Naftopidil

Naftopidil has been investigated for the treatment of Disorder of Urinary Stent.
Investigational
Matched Categories: … Calcium Channel Blockers ... Calcium-Regulating Hormones and Agents …

Salirasib

Salirasib has been used in trials studying the diagnostic of Carcinoma, Non-Small-Cell Lung.
Investigational
Matched Categories: … Calcium-Calmodulin-Dependent Protein Kinases, antagonists & inhibitors …

N-Pyridoxyl-1-Amino-Cyclopropanecarboxylic Acid-5-Monophosphate

Experimental

N-PYRIDOXYL-2-METHYL-L-GLUTAMIC ACID-5'-MONOPHOSPHATE

Experimental

Opaganib

Opaganib, also known as ABC294640, is a selective sphingosine kinase-2 (SK2) (https://go.drugbank.com/polypeptides/Q9NRA0) inhibitor that is orally administered. This drug has potential anticancer, anti-inflammatory, and antiviral activities, with potential applications in oncology, inflammation, the gastrointestinal system, and COVID-19.
Investigational

Monoisopropylphosphorylserine

Experimental

3'-Deazo-Thiamin Diphosphate

Experimental

Cyclic 3',5'-thymidine monophosphate

Experimental

1'-Deazo-Thiamin Diphosphate

Experimental

Zidovudine diphosphate

Experimental

(2R)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(9E)-HEXADEC-9-ENOYLOXY]PROPYL (9E)-OCTADEC-9-ENOATE

Experimental

2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate

Experimental

2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-D][1,3]Thiazolo[3,2-a]Pyrimidin-8-Yl}Ethyl Trihydrogen Diphosphate

Experimental
Displaying drugs 1201 - 1225 of 1335 in total